APA

Riely G. J., Kris M. G., Zhao B., Akhurst T., Milton D. T., Moore E., Tyson L., Pao W., Rizvi N. A., Schwartz L. H. & Miller V. A. (20070925). Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Riely Gregory J, Kris Mark G, Zhao Binsheng, Akhurst Tim, Milton Daniel T, Moore Erin, Tyson Leslie, Pao William, Rizvi Naiyer A, Schwartz Lawrence H and Miller Vincent A. 20070925. Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Riely G. J., Kris M. G., Zhao B., Akhurst T., Milton D. T., Moore E., Tyson L., Pao W., Rizvi N. A., Schwartz L. H. and Miller V. A. (20070925). Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Riely Gregory J, Kris Mark G, Zhao Binsheng, Akhurst Tim, Milton Daniel T, Moore Erin, Tyson Leslie, Pao William, Rizvi Naiyer A, Schwartz Lawrence H and Miller Vincent A. Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20070925.